Streptococcal Group B Infection Overview

Save information for later
Sign Up

Learn About Streptococcal Group B Infection

What is the definition of Streptococcal Group B Infection?
Group B streptococcus is a blood infection (septicemia) caused by the bacterium, Streptococcus agalactiae, which affects newborn babies. The infection is categorized into two syndromes: 1) early onset (<7 days old) and 2) late onset (7-90 days old). The infection can be caused when the baby moves through the birth canal (early onset), or the baby can become infected after birth through contact with carriers of the bacteria (late onset). Both syndromes can develop into pneumonia and meningitis.
What are the symptoms of Streptococcal Group B Infection?
Symptoms of Group B streptococcal infection in the newborn can include appearing anxious or stressed, blue skin (cyanosis), breathing difficulties, fast or slow heart rate, lethargy, pale, cold skin, poor feeding, and a low or high temperature.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Streptococcal Group B Infection?
The main treatment for Group B streptococcal infection in the newborn is intravenous (IV) antibiotics. Other treatments can include breathing support, intravenous fluids, treatment of shock, correction of blood clotting abnormalities, oxygen therapy, and, in severe cases, the use of a pump to circulate blood through an artificial lung (extracorporeal membrane oxygen).
Who are the top Streptococcal Group B Infection Local Doctors?
Thomas A. Hooven
Elite in Streptococcal Group B Infection
Dr. Thomas A. Hooven
Neonatology
Elite in Streptococcal Group B Infection
Dr. Thomas A. Hooven
Neonatology

UPMC Children's Hospital Of Pittsburgh, Pediatric Neonatology

4401 Penn Avenue, 
Pittsburgh, PA 
412-692-6851
Languages Spoken:
English
See accepted insurances

Thomas Hooven is a Neonatologist in Pittsburgh, Pennsylvania. Dr. Hooven is rated as an Elite provider by MediFind in the treatment of Streptococcal Group B Infection. His top areas of expertise are Streptococcal Group B Infection, Neonatal Sepsis, Premature Infant, and Necrotizing Enterocolitis.

Kirsty Le Doare
Elite in Streptococcal Group B Infection
Kirsty Le Doare
Elite in Streptococcal Group B Infection
Kirsty Le Doare
St George's University Of London, 
London, ENG, GB 

Kirsty Le Doare practices in London, United Kingdom. Ms. Le Doare is rated as an Elite expert by MediFind in the treatment of Streptococcal Group B Infection. Her top areas of expertise are Streptococcal Group B Infection, Neonatal Sepsis, Strep Throat, and Meningitis.

 
 
 
 
Learn about our expert tiers
Learn More
David M. Aronoff
Elite in Streptococcal Group B Infection
Dr. David M. Aronoff
Infectious Disease
Elite in Streptococcal Group B Infection
Dr. David M. Aronoff
Infectious Disease

Iu Health Medical Group LLC

1701 N Senate Blvd, 
Indianapolis, IN 
888-484-3258
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Aronoff is an Infectious Disease provider in Indianapolis, Indiana. Dr. Aronoff is rated as an Elite provider by MediFind in the treatment of Streptococcal Group B Infection. His top areas of expertise are Streptococcal Group B Infection, Strep Throat, Sepsis, and Pneumonia. Dr. Aronoff is currently accepting new patients.

View All Doctors
What are the latest Streptococcal Group B Infection Clinical Trials?
A Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants
A Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants
Enrollment Status: Recruiting
Publish Date: December 17, 2025
Intervention Type: Biological
Study Phase: Phase 3

Summary: BEATRIX (group B strEptococcus mATeRnal and Infant VaX study) The purpose of this study is to learn about the safety and how the group B streptococcus (GBS) vaccine works in pregnant women and their babies. This study is seeking healthy pregnant participants: * aged 49 or younger who can join. * between 24 and 36 weeks of gestation (Gestational age is a medical term used to describe how far along ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Randomized, Double Blind, Placebo Controlled, Two-Arms, Multicenter, Post Authorization Efficacy and Safety Study (PAES) to Confirm and Collect More Clinical Data of Buccalin® Tablets In the Prophylaxis of Recurrent Lower Respiratory Tract Infections (RLRTIs).
Randomized, Double Blind, Placebo Controlled, Two-Arms, Multicenter, Post Authorization Efficacy and Safety Study (PAES) to Confirm and Collect More Clinical Data of Buccalin® Tablets In the Prophylaxis of Recurrent Lower Respiratory Tract Infections (RLRTIs).
Enrollment Status: Recruiting
Publish Date: December 10, 2025
Intervention Type: Other, Drug
Study Phase: Phase 4

Summary: The goal of this clinical trial is to assess if BUCCALIN® works In the Prophylaxis of Recurrent Lower Respiratory Tract Infections (RLRTIS). It will also evaluate the safety of BUCCALIN®. The primary aim is to reduce the number of infection episodes in the treatment period (12 months) in the BUCCALIN® group versus the Placebo group. Patients diagnosed with RLRTIS will be screened for enrolment. Pa...

View All Clinical Trials